Overview

A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of single ascending (increasing) and multiple doses of GWP42006 compared with placebo.
Phase:
Phase 1
Details
Lead Sponsor:
GW Research Ltd